Trial intelligence / Profile preview

MTA vs Calcium Hydroxide for Direct Pulp Capping

NCT03403985Unknown

Sponsor
Jordan University of Science and Technology
Start
Jun 2017
Primary completion
Jun 2017
Countries
1
01

Overview

Randomised trial (2 arms), sponsored by Jordan University of Science and Technology. Primary endpoint: Clinical vital pulp therapy success up to 100 months. Status: unknown.

Beyond the preview

Go deeper on NCT03403985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03403985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call